Alitame’s roots go back to the late 1970s, when researchers at Pfizer set out to craft a sweetener that would stand up to heat and still taste clean. Early days saw an explosion of focus on aspartame, but the side hustle into alitame started paying dividends as chemists realized its dipeptide structure—built from alanine and aspartic acid, capped with a sweet-inducing amide—offered real punch for calorie-free applications. The race for patent rights picked up steam through the late twentieth century. Regulatory authorities poked, prodded, and reviewed hundreds of animal and human safety studies before the first approvals started showing up in Australia and Mexico. Many people—including myself as a consumer—heard about it much later, sometimes during heated dinner-table debates about which tabletop sweetener cut it taste-wise and which ones drifted into the realm of metallic or bitter aftertastes.
Alitame stands out. It measures roughly 2,000 times sweeter than table sugar and lands among the rare non-saccharide synthetic sweeteners that actually mimic the flavor profile of sucrose. Often sold as fine, white, odorless powder, its low calorie count makes it a staple for folks chasing sweetness without the baggage of extra carbohydrates. Companies that package or use alitame in their products usually blend it, since pure alitame’s sweetness packs too much punch for direct use. You find it turning up in low-calorie drinks, chewing gum, desserts, yogurts, and sauces—any application where some heat resistance and clean taste tip the balance.
Alitame’s molecular formula, C14H25N3O4S, points to its status as a dipeptide amide, engineered for maximum sensory impact. The compound appears as a white crystalline solid. It dissolves well in water, a must for beverage production. It shows off a melting point in the neighborhood of 110°C, reassuring food technologists that low-level heat during baking or pasteurization won’t wreck the flavor. Alitame resists acid hydrolysis much more robustly than aspartame, holding its sweetness in soft drinks or yogurt cultures that tend toward lower pH.
In any ingredient list, even the smallest trace of alitame must show up—regulators insist. Most countries set strict limits for how much ends up inside each serving. For example, the Australian/New Zealand Food Standards Code rolled out maximum levels for every food category, so manufacturers don’t slip past safety boundaries. The typical product spec sheet outlines minimum assay requirements (not less than 98% content), moisture limits (usually below 5%), and purity statements for heavy metals or solvents. Labels rarely bury alitame under confusing names; the acronym “E956” does the job across much of Europe and Asia.
Synthesis often kicks off with aspartic acid and D-alanine derivatives as early starting materials, leveraging peptide coupling methods to form the main molecular connection. Key steps include selective protection and deprotection of the amine groups to steer the reaction toward the right amide linkage. Once chemists forge that backbone, they add the crucial sulfamic acid group. As the yields increase and by-products drop out, the mixture goes through crystallization and recrystallization to give a pure, food-grade powder, fit for formulation. This process draws heavily from decades of peptide chemistry, emphasizing tight process control and thorough purification to clear regulatory inspections.
Rather than being inert, alitame’s structure can undergo specific changes under the right conditions. Exposure to strong acids over extended periods causes hydrolysis of the amide bond, reducing sweetness. Mild processing temperatures or neutral pH rarely make a dent; that’s one reason why manufacturers trust it in acidic beverages. Chemical modifications attract interest in the research community, especially for designing analogues with longer shelf lives or unique flavor profiles. My own review of published data points to advances in tweaking end groups and substituting functional units, sometimes leading to derivatives with improved stability or new sweetener blends.
Alitame does not have a wild name history—“E956” travels far in EU regulation and “Aclame” shows up in some commercial product rosters. In chemistry circles, the names L-α-Aspartyl-N-(2,2,4,4-tetramethyl-3-thietanyl)-D-alaninamide or AI-77-373 cover it in more clinical documents. Marketers prefer “alitame” for clarity, so you’ll rarely see those mouthfuls on a store shelf.
Any company making or handling alitame works under a tangle of hygiene, cross-contamination, and occupational exposure requirements. Factory workers suit up and keep powder containment tight—sweeteners like this waft easily in air and attract critters. Facilities install monitoring for airborne particulates. Global food codes, such as Codex Alimentarius and local FDA equivalents, lay out procedures for quality control, lot traceability, and chemical analysis. The presence of sulfamic acid means that facility staff keep spill response materials handy, since spills or direct skin contact need rapid cleanup. I have visited operations where batch testing included not only purity checks, but also real-world baking and cooking trials to confirm consistency in taste and performance.
You find alitame giving backbone to a long list of zero-calorie and reduced-calorie products. Beverage companies like its clean finish and heat stability for shelf-stable sodas and flavored milks. Bakeries get steady performance in cookies and pastries. Dairy producers like it in custards and yogurts; the sweetener stands up to acidic fermentation without breaking down. Chewing gum makers grab onto its flavor longevity, while frozen dessert developers blend it to boost cold sweetness in ice cream and sorbet. In kitchens, it offers home cooks a sugar replacement that resists bitterness when mixed into hot or acidic dishes. Over the past decade, I have seen an uptick in research papers citing its blendability with other sweeteners, chasing after the ever-elusive “just like sugar” taste experience.
The present wave of R&D has focused on new delivery forms for alitame: encapsulated particles, slow-release films, or microgranules designed for use in both food and pharmaceuticals. Researchers are continually revisiting animal and in vitro metabolism studies to chart how the human body processes the compound, ensuring novel blends stay inside accepted safety parameters. Some groups aim to lower production costs using enzyme-assisted synthesis or greener solvents. Others analyze stability under new packaging conditions, or look for off-flavors that might develop after months on the shelf. My experience reviewing patent applications hints at steady progress—every year brings small advances that nudge alitame closer to widespread adoption.
Toxicologists ran alitame through a battery of acute and chronic tests in rodents, dogs, and primates long before it touched grocery shelves. The overwhelming bulk of studies found no observable adverse effect levels (NOAEL) at doses far higher than any human consumes; this evidence shapes government guidelines for acceptable daily intake. Rigorous studies account for metabolic byproducts, allergic reactions, and cumulative organ effects. Regulatory agencies in Australia, China, and Mexico set their own ADI guidelines based on independent safety reviews. Scientists have scrutinized its breakdown products, confirming the amino acid fragments get processed like other dietary proteins, even in sensitive populations.
Alitame’s story is not finished. With the world fixated on obesity prevention and diabetes rates, every innovation that helps replace sugar remains in the spotlight. Ongoing research looks for ways to cheapen manufacture, refine blends, and dial back even the faintest aftertaste for picky palates. Regulatory acceptance still stalls in some big markets, notably the United States and Europe, where extra safety data is often demanded. As new consumer trends drift toward plant-based and “clean label” formulations, alitame faces challenges but also new opportunities if manufacturers can position it as a safe, trusted, and beneficial alternative. The quest for the perfect sweetener will keep labs buzzing—as it always has—pushing old favorites like alitame into new directions, both in food science and public health.
Alitame came onto the scene as a synthetic sweetener promising to shake up the food industry. With growing concern about sugar’s impact on health, people want options that let them enjoy sweetness without the side effects. Alitame promised to deliver, offering about 2,000 times the sweetness of regular sugar. In my experience browsing snack aisles and reading nutrition labels, alternatives often come with trade-offs. Saccharin caused a stir over health risks, and aspartame draws attention because of debates about neurological effects. Alitame drew people in because of its taste profile, safety claims, and ability to withstand heat, which opens doors for more cooking and baking uses than with some earlier sweeteners.
I’ve noticed that sweeteners wind up in more foods than people realize. With alitame, major companies eye its potential for soft drinks, yogurts, flavored waters, gums, and low-calorie desserts. The reason is simple—less product goes further. Less volume makes it easier to reduce calories without losing sweetness. Unlike acesulfame potassium or stevia, alitame leaves less aftertaste, which appeals to folks put off by the metallic or bitter notes in many “diet” foods. You don’t have to worry about it vanishing under heat, so manufacturers lean on it for shelf-stable foods that need to travel long distances or stay in a pantry for months.
Some folks push back whenever a new additive arrives. Alitame hasn’t been cleared in the United States, thanks to debates about its long-term health impact. The Joint FAO/WHO Expert Committee on Food Additives examined evidence and set an acceptable daily intake, lending some weight to its safety. Still, regulatory agencies like the FDA remain cautious, partly because new research on food chemicals turns up unexpected findings with large-scale human exposure. People worry about stuff like toxicity, cancer risk, and allergic reactions, even though published animal studies have shown low toxicity for alitame. We need better human studies and transparency from manufacturers to build trust.
Rising concern about obesity and diabetes is shaping how we eat. Cutting sugar seems like the obvious solution, so food scientists chase an elusive, safe sugar substitute that tastes “right.” Alitame ticks some boxes—it works well in blends, sweetens efficiently, keeps calories down, and pairs well with acidic drinks. It makes it possible to create lower-sugar options without a chemical taste. Companies save on ingredient and transportation costs, since small amounts do a lot. That is an advantage that appeals to both the manufacturer’s bottom line and the shopper looking for “lite” options.
Regulatory agencies and research institutions have a responsibility to keep up with food chemistry as quickly as industry innovates. If alitame or another alternative sweetener moves toward mainstream approval, the public deserves clear, ongoing communications about findings—especially around health risks, dosage, and long-term exposure. Journalists and educators can play a role by translating dense research into language people actually use on the street or at their kitchen table. Shoppers want honest answers, not marketing hype. If new data point to risks, that news needs to travel as fast and wide as the next big product launch.
Alitame pops up in conversations about artificial sweeteners alongside aspartame and sucralose. Developed in the 1980s by Pfizer, alitame sweetens foods at only a fraction of the amount regular sugar needs. It’s been pitched as a low-calorie answer for people with diabetes, those keeping an eye on their sugar intake, and anyone wanting to skip the extra calories. Markets in Australia, China, and Mexico allow food companies to use alitame. The U.S. Food and Drug Administration has reviewed it but hasn’t approved it for use yet.
I’ve chatted with doctors and nutritionists over coffee about sweeteners for years, listening to different opinions. Some say they use them daily without trouble. Others express worry about long-term effects, mentioning headaches and stomach problems after eating certain diet foods. The reality: not all sweeteners act the same, and the way our bodies process alitame sets it apart.
Research published by global food safety agencies, including the Joint FAO/WHO Expert Committee on Food Additives, points out that alitame breaks down in the body to aspartic acid, alanine, and a tiny bit of methanol—the same breakdown products as many protein-rich foods and even some fruits. High-dose animal trials haven’t shown cancer risk, reproductive damage, or changes in major organs. At reasonable dietary levels, no evidence of nerve damage or serious health problems popped up in published studies.
Why hasn’t alitame passed the U.S. regulatory process? Despite solid safety data from animal studies, key regulatory players worry about possible unknowns in long-term, widespread exposure. Some data remain unpublished or older than ideal. The FDA often errs on the side of caution, waiting for fresh, large-scale studies before green-lighting new additives. It’s also a truth that plenty of food additives face hesitation, not necessarily from safety, but market demand or business decisions.
Europe’s authorities judged the available evidence as supportive, but food manufacturers never lined up to use alitame there. Demand for new sweeteners can shift quickly, with sugar alcohols and “natural” options like stevia catching headlines instead.
Sugar substitutes regularly appear in the news. My own experience tells me moderation matters far more than any ingredient’s headline risk. Over the years, people tend to use too much not just because they enjoy the sweetness, but because “calorie-free” seems like a free pass. Nutrition labels often hide added sweeteners under different names, which complicates things, especially for folks managing health conditions.
Cooks and families who want full transparency should pay attention to food labels, and reach for whole foods more often than processed ones. If a sweetener isn’t familiar or approved in your local market—like alitame in the U.S.—few reasons exist to chase after it when so many tested options line the shelves. Nothing beats a balanced approach: real fruit in yogurt, or just using less sugar for coffee.
Talk with your doctor or registered dietitian before trying unfamiliar sweeteners if you have a health condition. Check guidance from respected agencies (like the FDA and EFSA) rather than relying on influencers or websites promising miracle claims. Ask food companies for clarity if you see an unknown ingredient on the label.
Science evolves, and so do food safety rules. Until a new ingredient earns trust through years of real-world use and hard data, a little skepticism protects both wallets and well-being.
Alitame showed up in the sweetener world promising something different, and after using other options for years, it’s hard not to notice the difference. At its core, Alitame delivers a high intensity of sweetness—about 2,000 times sweeter than table sugar—without a bitter or chemical aftertaste. Anyone who’s tried aspartame or saccharin knows how those aftertastes linger, sometimes ruining a drink or dessert. Alitame seems to get around that issue, offering a mild, clean finish that resembles real sugar.
A lot of us look for sweeteners when we want fewer calories or need a sugar alternative because of health concerns. Unlike sugar, Alitame contains almost no calories. It also creates fewer blood sugar spikes since it barely affects glucose levels. For people managing diabetes or anyone wanting to avoid metabolic swings, this helps. The story gets better—Alitame remains stable under high temperatures, so it doesn’t break down or form potentially harmful byproducts, even in baking or hot drinks, where aspartame and some other sweeteners fall short.
Anyone who's tried low-calorie beverages or sugar-free yogurt knows the challenges: bitterness or a lingering taste that doesn’t taste like real sugar at all. Stevia delivers sweetness but sometimes brings a licorice-like flavor, and sucralose occasionally leaves a chemical trace. Alitame, thanks to its amino acid structure, avoids these side effects for most people. After switching to Alitame, even family and friends who usually avoid diet products because of aftertaste found it hard to notice any difference from regular sugar in baked goods and coffee.
Trust matters with food ingredients. Regulatory agencies in places like the European Union and Australia have run extensive reviews on Alitame. No evidence shows harmful effects when used in reasonable amounts, and it’s not metabolized to phenylalanine, which causes problems for people with phenylketonuria—a rare but serious genetic disorder. That’s a relief for anyone who’s had to carefully scan labels for aspartame warnings.
Research published in journals such as Food and Chemical Toxicology covers everything from cancer risks to chronic exposure. After decades of data, no link to harmful health outcomes has surfaced. Scientific backing gives consumers the confidence they need, and it helps guide food companies that want to provide safe sugar alternatives.
Food producers care about shelf life and manufacturing costs. Alitame doesn’t break down as quickly as some sweeteners during storage, so products can stay sweet longer. Only tiny amounts deliver the same sweetness of much more sugar or other alternatives, bringing costs down for large-scale manufacturers. In the kitchen, Alitame keeps its structure under both acidic and basic conditions (like soda formulations), which gives it an edge over sweeteners that fall apart or lose sweetness. It works well alongside other sweeteners for custom blends that get the right taste and cost balance.
Obesity rates and metabolic syndrome cases keep rising. Many experts point the finger at excess sugar. The push for better alternatives makes Alitame more relevant. It offers manufacturers and home cooks a powerful tool—strong sweetness, minimal calories, and fewer taste or health complaints compared to older options. If food companies pick ingredients like Alitame more often in the future, healthier food and drink options could become more accessible, helping people transition away from high-calorie diets.
Artificial sweeteners always spark debate around safety, side effects, and their place in food. Alitame is one of those names that comes up sometimes, usually in conversations where people already know about aspartame or sucralose. It’s a high-intensity sweetener, hundreds of times sweeter than table sugar. Food companies hoped it would work for folks who want fewer calories or have diabetes. It did get some interest in the 1990s, mostly outside the United States. Today, you won’t see it in American grocery aisles. The FDA decided not to approve it, partly because of questions about safety and long-term health effects.
Alitame’s chemical structure sets it apart from others. It breaks down into aspartic acid, alanine, and a little bit of methanol. Methanol in small amounts doesn’t send people rushing to the emergency room; our bodies process it quickly, especially from natural sources like fruit. But the conversation shifts with regular use of anything synthetic. Safety studies did not show a pattern of severe problems at normal usage, though some groups remained cautious and demanded more long-term research. Part of the problem: Alitame breaks down in heat and acid, which worried companies who wanted it stable in sodas and desserts.
If you ask people who have tried alitame-sweetened foods, most don’t report immediate side effects—not in the way that some folks are sensitive to sorbitol or certain sugar alcohols. Some animal studies raised flags about possible liver and kidney effects at very high doses, much higher than what regular consumers would ever eat. Regulatory agencies took a hard look at those findings, but never found overwhelming evidence to justify outright bans. Still, lack of approval in major markets like the US carries weight. That tells a story even if it's not written in headlines.
The bigger questions come from the same place as debates over other sweeteners: Do these artificial things really help people lose weight or control blood sugar? The answer is fuzzy. Some population studies show diet drinks packed with sweeteners don’t always lead to slimmer waistlines. Taste preferences may shift, making regular foods seem bland. Some researchers speculate these chemicals might disrupt brain chemistry linked to appetite and cravings. Alitame has not been studied as much as aspartame, so the evidence can’t settle the argument either way.
The story with artificial sweeteners is about trade-offs. Food safety watchdogs recommend moderation and variety. Over several years in science news and health writing, I noticed most real problems come from overuse, limited transparency, or poor labeling. Solutions start there—clear labels, open research data, and independent studies testing what happens to real people, not just lab animals or cultured cells. For anyone worried about possible side effects, checking with a healthcare provider makes sense, especially if you have allergies or chronic health conditions. If enough people ask questions, companies and regulators know folks are paying attention and demand better answers. That’s how progress usually happens beyond the lab.
People care a lot about what’s in their food. The sweetener alitame came on the scene with big promises. It’s much sweeter than sugar, doesn’t bring calories, and the aftertaste bothers fewer people compared to other artificial options. Still, you don’t see it on every store shelf around the world. So the question keeps coming up: has every country greenlit alitame? The answer’s a straightforward “no,” but the reasons run deep.
Alitame packs a punch – about 2,000 times sweeter than sugar. Chemists designed it in the ‘80s to give people a sweeter life without the calories or blood sugar spikes. It’s stable in hot drinks and can handle some processing, making it more flexible than aspartame in cooking. Tastes pretty close to sugar, without a bitter or metallic note that lingers in some other sweeteners. Food scientists and beverage companies were excited, and so were many of us looking to kick sugar.
Regulatory bodies don’t flip the yes/no switch without a long process. The U.S. Food and Drug Administration never gave alitame the green light, partly because the company behind it decided to pull their application. Some reports say it just wasn’t worth the cost for them in a crowded artificial sweetener market. In the European Union, the story takes a different turn: EFSA reviewed the available data and decided safety evidence fell short of what they wanted to see. They felt the risk for the general population couldn’t be ruled out, mostly based on limited studies about toxicity and metabolism. So, you won’t find alitame in foods on European grocery shelves either.
Australia and New Zealand looked at alitame with a critical eye and chose to keep it off the approved list. Some countries in Asia, like China, have said yes, so you might see it in products there. This patchwork confuses shoppers who travel or import foods, and it leaves global food brands scratching their heads on whether or not to include it in their formulas.
People want to trust what’s inside their meals. The alitame story shows what happens when the science doesn’t come across in a way regular folks can check for themselves. Years ago, parents, teachers, and doctors worried after hearing mixed messages about other sweeteners, like aspartame or saccharin. Those stories stick. If regulatory boards find gaps in long-term health data, many hold off approval, which is responsible, but often leaves the public wondering what’s going on. Food makers sometimes move on if there’s a risk of backlash or confusion.
Looking at the bigger picture, regular updates and plain-language findings from trusted food safety science sources go a long way. It helps people make choices, whether they want to avoid artificial sweeteners, require them for health reasons, or just like to know what’s up. Companies hoping to launch new food additives would do well to work within the process, gather more data, and take transparency seriously. Regulators keeping the public looped in, even about “no” decisions, builds trust, no matter where you live.
| Names | |
| Preferred IUPAC name | (3S)-3-Amino-4-[[(2,2,4,4-tetramethyl-3-thietanyl)amino]carbonyl]butanoic acid |
| Other names |
Aditame L-aspartyl-D-alanine (L-Asp-D-Ala) |
| Pronunciation | /ˈælɪteɪm/ |
| Preferred IUPAC name | (3S)-2,6-diamino-N-(1-methoxycarbonyl-ethyl)-hexanamide |
| Other names |
Aclame Aditame |
| Pronunciation | /ˈæl.ɪ.teɪm/ |
| Identifiers | |
| CAS Number | 80863-62-3 |
| Beilstein Reference | 3113942 |
| ChEBI | CHEBI:37635 |
| ChEMBL | CHEMBL2104746 |
| ChemSpider | 57902 |
| DrugBank | DB04532 |
| ECHA InfoCard | 03e2210c-6c85-41ce-b9fc-987a0b81c8ca |
| EC Number | E956 |
| Gmelin Reference | 108658 |
| KEGG | C14141 |
| MeSH | D019355 |
| PubChem CID | 5311021 |
| RTECS number | AW1246000 |
| UNII | XN6001648V |
| UN number | UN number: "UN2811 |
| CompTox Dashboard (EPA) | DTXSID2020194 |
| CAS Number | 80863-62-3 |
| Beilstein Reference | 3493043 |
| ChEBI | CHEBI:61008 |
| ChEMBL | CHEMBL2104741 |
| ChemSpider | 214051 |
| DrugBank | DB04526 |
| ECHA InfoCard | InChIKey=ZBQCXQOEWJMVBW-FXULWYPXSA-N |
| EC Number | E956 |
| Gmelin Reference | 540113 |
| KEGG | C14070 |
| MeSH | D017015 |
| PubChem CID | 5284417 |
| RTECS number | AW2225000 |
| UNII | R1GP51604D |
| UN number | UN1993 |
| CompTox Dashboard (EPA) | DTXSID2020187 |
| Properties | |
| Chemical formula | C14H25N3O4S |
| Molar mass | 458.48 g/mol |
| Appearance | white crystalline powder |
| Odor | Odorless |
| Density | 1.21 g/cm³ |
| Solubility in water | Soluble |
| log P | 0.6 |
| Vapor pressure | Insubstantial (estimated) |
| Acidity (pKa) | 3.92 |
| Basicity (pKb) | 2.3 |
| Magnetic susceptibility (χ) | -44.5·10⁻⁶ cm³/mol |
| Dipole moment | 2.98 D |
| Chemical formula | C14H25N3O4S |
| Molar mass | 458.55 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.21 g/cm³ |
| Solubility in water | Slightly soluble |
| log P | 1.60 |
| Vapor pressure | Negligible |
| Acidity (pKa) | 2.1 |
| Basicity (pKb) | 2.62 |
| Magnetic susceptibility (χ) | -39.2e-6 cm³/mol |
| Dipole moment | 4.04 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | Alitame: 564.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | 256.8 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3735 kJ/mol |
| Std molar entropy (S⦵298) | 545.8 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -3620 kJ/mol |
| Pharmacology | |
| ATC code | Acesulfame |
| ATC code | A01AD07 |
| Hazards | |
| GHS labelling | GHS labelling of Alitame: `"Not a hazardous substance or mixture according to the Globally Harmonized System (GHS)"` |
| Pictograms | acute toxicity, harmful, environment |
| Signal word | No signal word |
| Hazard statements | No hazard statements. |
| Precautionary statements | IF INHALED: Remove person to fresh air and keep comfortable for breathing. IF ON SKIN: Wash with plenty of water. IF IN EYES: Rinse cautiously with water for several minutes. If eye irritation persists: Get medical advice/attention. |
| NFPA 704 (fire diamond) | 0-1-0 |
| Autoignition temperature | 800 °C |
| Lethal dose or concentration | Rat oral LD₅₀: 3,700 mg/kg |
| LD50 (median dose) | 3500 mg/kg |
| NIOSH | DJ7000000 |
| PEL (Permissible) | 1 mg/kg bw |
| REL (Recommended) | 0-1 mg/kg bw |
| Main hazards | May cause respiratory irritation. |
| GHS labelling | GHS labelling of Alitame: "Not a hazardous substance or mixture according to the Globally Harmonized System (GHS) |
| Pictograms | ADI;E-number;Sweetener;Amino acid based;Not permitted in EU/US;Artificial |
| Signal word | No signal word |
| Hazard statements | No known hazard statements. |
| NFPA 704 (fire diamond) | 1-0-0 |
| Autoignition temperature | 800 °C |
| Explosive limits | Not explosive |
| Lethal dose or concentration | LD50 (rat, oral): 3,672 mg/kg |
| LD50 (median dose) | LD50 (median dose): 3,238 mg/kg (rat, oral) |
| NIOSH | A3180 |
| PEL (Permissible) | 1 mg/kg |
| REL (Recommended) | 0.3 mg/kg bw |
| IDLH (Immediate danger) | Not listed |
| Related compounds | |
| Related compounds |
Aspartame Sodium aspartate Acesulfame potassium |
| Related compounds |
Aspartame Saccharin Acesulfame potassium |